Big Money Sentiment decreased to 1.28 in 2018 Q4. It has change of 0.84, from 2018Q3’s 2.12. The ratio turned negative due to Castlight Health, Inc. positioning: 10 sold and 26 reduced. 20 funds acquired positions and 26 increased positions. Investors holded 59.74 million in 2018Q3 but now own 63.42 million shares or 6.18% more.
Redmile Grp Inc Ltd Liability Co has 10,229 shs. Ubs Asset Americas Inc accumulated 0% or 46,500 shs. Hamilton Lane Ltd Liability invested 0.05% in Castlight Health, Inc. (NYSE:CSLT). 40,700 are held by California Pub Employees Retirement System. Raging Cap Mgmt Lc stated it has 717,709 shs. Engineers Gate Manager Limited Partnership has 0.01% invested in Castlight Health, Inc. (NYSE:CSLT). Gagnon Advsrs Ltd Co accumulated 1.78% or 1.17 million shs. Checchi Capital Advisers Limited Liability Company reported 10,000 shs. Maverick Capital Ltd owns 1.77M shs. Barclays Public Limited Com accumulated 30,032 shs. California-based Rice Hall James And Associate Ltd Liability Corp has invested 0.04% in Castlight Health, Inc. (NYSE:CSLT). Gagnon Securities Ltd Llc reported 1.98M shs. Jacobs Levy Equity has invested 0% in Castlight Health, Inc. (NYSE:CSLT). New York-based Edge Wealth Ltd Liability has invested 0.07% in Castlight Health, Inc. (NYSE:CSLT). Credit Suisse Ag has 34,912 shs for 0% of their capital.
Castlight Health, Inc. had 11 sales and 0 insider purchases since November 15, 2018. This’s net activity of $379,455. 26,045 shs were sold by Gupta Neeraj, worth $67,483. On Monday, November 19 a trade for 13,997 shs valued at $36,648 was made by Nolan Mangini Siobhan. On Monday, November 19 a trade for 7,406 shs valued at $19,541 was made by Chan M.P. Eric. 18,519 shs valued at $49,866 were sold by DOYLE JOHN C on Monday, November 19.
On May, 9 Castlight Health, Inc. (NYSE:CSLT)’s earnings report is expected by WallStreet, as reported by Faxor. This year’s earnings per share analyst estimate is expected to be $-0.05. That is 44.44 % up compareed to $-0.09 earnings per share for last year. After $-0.01 EPS report last quarter, Wall Street now forecasts 400.00 % negative EPS growth of Castlight Health, Inc.. Ticker’s shares touched $3.74 during the last trading session after 4.59% change.Castlight Health, Inc. has volume of 329,326 shares. Since April 14, 2018 CSLT has risen 11.55% and is uptrending. CSLT outperformed the S&P 500 by 7.18%.
Castlight Health, Inc. (NYSE:CSLT) Ratings Coverage
In total 2 analysts cover Castlight Health (NYSE:CSLT). “Buy” rating has 1, “Sell” are 0, while 1 are “Hold”. (NYSE:CSLT) has 50% bullish analysts. 2 are the (NYSE:CSLT)’s ratings reports on Apr 14, 2019 according to StockzIntelligence Inc. In Thursday, February 28 report Cantor Fitzgerald maintained it with “Buy” rating and $5 target. On Monday, March 4 the rating was maintained by Wells Fargo with “Hold”.
Castlight Health, Inc. operates a health benefits platform in the United States.The firm is valued at $536.78 million. The company's platform engages employees to make better health decisions and enables employers to communicate and measure their benefit programs.Currently it has negative earnings. The Company’s platform also provides real-time insight into employee engagement with benefits and programs enabling employers to monitor and adjust their strategies.
For more Castlight Health, Inc. (NYSE:CSLT) news brought out briefly go to: Benzinga.com, Seekingalpha.com, Zacks.com, Seekingalpha.com or Seekingalpha.com. The titles are as follows: “64 Stocks Moving In Friday’s Mid-Day Session – Benzinga” brought out on March 01, 2019, “Castlight Health, Inc. 2018 Q4 – Results – Earnings Call Slides – Seeking Alpha” on March 01, 2019, “Castlight (CSLT) to Report Q4 Earnings: What’s in the Cards? – Zacks.com” with a publish date: February 27, 2019, “New Dawn At Castlight Health – Seeking Alpha” and the last “Castlight Health -27% on Q2 beats with restructuring plan – Seeking Alpha” with publication date: July 31, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.